With these positive data in hand, we are moving with urgency toward global regulatory submissions to potentially meet the needs of patients who are waiting, said Kenneth Custer, executive vice president of Eli Lilly and president of Lilly Cardiometabolic Health, in a statement from the company
Glucose-dependent insulinotropic polypeptide: Blood glucose stabilizing effects in patients with type 2 diabetes
Regular check-ups allow for monitoring progress, addressing any side effects, and making necessary adjustments to the treatment plan
Hormonal imbalances can influence lipid metabolism, exacerbating dyslipidemia and increasing the risk of cardiovascular disease
And they're like, that's because you're not exercising enough because you're a mom and everything was, you're a mom